CHILIN, ADRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.160
AS - Asia 7.008
EU - Europa 3.157
SA - Sud America 1.162
AF - Africa 1.132
Continente sconosciuto - Info sul continente non disponibili 151
OC - Oceania 99
Totale 25.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.518
SG - Singapore 2.208
CN - Cina 1.373
VN - Vietnam 1.006
BR - Brasile 713
HK - Hong Kong 593
IT - Italia 534
DE - Germania 341
BD - Bangladesh 310
FR - Francia 300
FI - Finlandia 286
IN - India 220
SE - Svezia 193
GB - Regno Unito 158
PL - Polonia 140
UA - Ucraina 137
NL - Olanda 130
IQ - Iraq 114
CA - Canada 111
AR - Argentina 102
RU - Federazione Russa 102
TR - Turchia 95
JP - Giappone 80
PK - Pakistan 78
ZA - Sudafrica 75
PH - Filippine 70
MX - Messico 66
ID - Indonesia 63
SA - Arabia Saudita 62
EC - Ecuador 61
ES - Italia 56
VE - Venezuela 52
UZ - Uzbekistan 51
CO - Colombia 49
CI - Costa d'Avorio 46
TN - Tunisia 45
AT - Austria 44
JM - Giamaica 44
EG - Egitto 43
GR - Grecia 43
UY - Uruguay 41
AO - Angola 40
HN - Honduras 40
CR - Costa Rica 39
IE - Irlanda 37
RO - Romania 37
RS - Serbia 37
TT - Trinidad e Tobago 37
IR - Iran 36
LV - Lettonia 36
MY - Malesia 35
CH - Svizzera 34
KR - Corea 34
PA - Panama 34
BJ - Benin 33
DZ - Algeria 33
PS - Palestinian Territory 33
PY - Paraguay 33
TH - Thailandia 33
CZ - Repubblica Ceca 32
ET - Etiopia 32
GA - Gabon 32
KE - Kenya 32
LB - Libano 32
UG - Uganda 32
EE - Estonia 31
GF - Guiana Francese 31
JO - Giordania 31
NI - Nicaragua 31
KG - Kirghizistan 30
LY - Libia 30
MA - Marocco 30
MD - Moldavia 30
AE - Emirati Arabi Uniti 29
AL - Albania 29
AU - Australia 29
BE - Belgio 29
BG - Bulgaria 29
BO - Bolivia 29
CV - Capo Verde 29
PE - Perù 29
PT - Portogallo 29
AZ - Azerbaigian 28
MN - Mongolia 28
MW - Malawi 28
RW - Ruanda 28
SK - Slovacchia (Repubblica Slovacca) 28
TZ - Tanzania 28
DO - Repubblica Dominicana 27
HR - Croazia 27
MG - Madagascar 27
MU - Mauritius 27
YT - Mayotte 27
IL - Israele 26
MR - Mauritania 26
NE - Niger 26
TW - Taiwan 26
AF - Afghanistan, Repubblica islamica di 25
BB - Barbados 25
DK - Danimarca 25
Totale 24.573
Salva come PNG Salva come JPEG
Città #
Ashburn 1.446
Singapore 1.400
San Jose 1.172
Fairfield 1.168
Woodbridge 1.091
Ann Arbor 852
Chandler 668
Houston 653
Hong Kong 535
Wilmington 524
Jacksonville 514
Cambridge 443
Seattle 425
Beijing 336
Santa Clara 304
Ho Chi Minh City 243
Princeton 207
Hanoi 199
Dong Ket 198
Boardman 190
Los Angeles 174
Des Moines 136
Helsinki 125
New York 120
Lauterbourg 119
San Diego 99
Nanjing 95
Munich 91
Bytom 81
Padova 72
Buffalo 67
São Paulo 67
Medford 59
Milan 57
Chicago 53
Tokyo 53
Da Nang 52
Roxbury 51
Baghdad 49
Abidjan 46
Guangzhou 45
Orem 44
Tashkent 44
The Dalles 42
Brooklyn 37
Johannesburg 37
Council Bluffs 34
Montevideo 34
Frankfurt am Main 33
Shenyang 33
Kampala 32
Luanda 32
Rome 32
Libreville 31
Panama City 31
Turku 31
Vienna 31
Haiphong 30
Managua 30
Warsaw 30
Cotonou 29
Dallas 29
Amman 28
Kigali 28
Riga 28
San José 28
Baku 27
Chennai 27
Addis Ababa 26
Antananarivo 26
Atlanta 26
Dublin 26
Istanbul 26
Nairobi 26
Nouakchott 26
Praia 26
Ulan Bator 26
Bishkek 25
Dakar 25
Kingston 25
Riyadh 25
Tallinn 25
Jeddah 24
London 24
Niamey 24
Tianjin 24
Tunis 24
Washington 24
Dar es Salaam 23
Lahore 23
Nanchang 23
Andorra la Vella 22
Lusaka 22
Phnom Penh 22
Tripoli 22
Belgrade 21
Boston 21
Bridgetown 21
Changsha 21
Dushanbe 21
Totale 15.916
Salva come PNG Salva come JPEG
Nome #
1,4,8-Trimethylfuro[2,3-H]quinolin-2(1H)-one, a new furocoumarin bioisoster 469
Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties 287
Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain 286
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 280
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 274
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors 270
Synthesis and biological evaluation of a new furo[2,3-h]quinolin-2(1H)-one 267
Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism 261
4-Hydroxymethyl-1,6,8-trimethylfuro [2,3-h] quinolin-2 (1H)-one induces mitochondrial dysfunction and apoptosis upon its intracellular oxidation 257
Photobiological properties of 1-(3'-hydroxypropyl)-4,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one, a new furocoumarin analogue 248
DNA damage induced by 4,6,8,9-Tetramethyl-2H-furo[2,3-h]quinolin-2-one, a new furocoumarin analog: Photochemical mechanisms 247
Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties 246
Novel benzoquinoline derivatives via unpredicted condensation of ethyl propiolate and naphthylamines: Synthesis and topoisomerase inhibition activity 246
2,6-Dimethyl-9-methoxy-4H-pyrrolo[3,2,1-ij]quinolin-4-one, a new compound with unusual photosensitizing properties. - 243
Targeting kinases with anilinopyrimidines: Discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily 243
Azapsoralens and benzoazapsoralens as new potential photochemo-therapeutic agents 241
A new access to quinazolines from simple anilines 239
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 237
Mechanism of Action of 4-Hydroxymethyl-1,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one, a Very Active Angular Furocoumarin-like Sensitizer 235
Difurocoumarins: Psoralen analogs as photochemotherapeutic agents 234
New Vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential. 234
Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB) 234
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 232
Pyrazoloquinazoline tricyclic system as novel scaffold to design new kinase CK2 inhibitors 231
Autogrid-based clusterization of kinases: selection of representative conformations for docking purposes 230
Psoralen Derivatives as Inhibitors of NF-κB/DNA Interaction: Synthesis, Molecular Modeling, 3D-QSAR, and Biological Evaluation 228
Angular Furoquinolinones, Psoralen Analogs:  Novel Antiproliferative Agents for Skin Diseases. Synthesis, Biological Activity, Mechanism of Action, and Computer-Aided Studies 228
4-Hydroxymethyl- and 4-methoxymethylfuro[2,3-h]quinolin-2(1H)-ones: Synthesis and Biological Properties 227
4-Hydroxymethyltetrahydro- and 4-hydroxymethyl-benzopsoralen: synthesis and biological activity. 226
Synthesis of some benzo[c][2,6]naphthyridin-5-ones and new tetracyclic benzofuro[4,5-c]-2,6-naphthyridin-5(6H)-ones 225
A microwave improvement in the synthesis of the quinazoline scaffold 224
The Importance of Descriptor-Based Clusterization in QSAR Models Development: Tyrosine Kinases Inhibitors as a Key Study 224
Benzoquinazoline derivatives as new agents affecting DNA processing. 223
Synthesis of methyl derivatives of 4H-furo[2,3-h]quinolin-4-one and 5H-furo[3,2-g]quinolin-5-one 222
4,4',5'-Trymethyl-8-azapsoralen, a new photereactive and non-skin-phototoxyc bifunctional bioisoster of psoralen. 220
Psoralenquinones as a Novel Class of Proteasome Inhibitors: Design, Synthesis and Biological Evaluation 219
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma 219
Pegylated enzyme entrapped in poly(vinyl alcohol) hydrogel for biocatalytic application 218
A novel convenient synthesis of benzoquinazolines 217
1H-NMR Spectra of variously annulated furocoumarins 216
Synthesis and Biological Activity of Hydroxymethyl and Diethylaminomethylbenzopsoralens. 216
Synthesis and biological properties of some 2H-1-benzopyran [7,8-b][1,4]benzodioxin-2-ones. 216
A novel phenolic derivative inhibits AHL-dependent Quorum Sensing signaling in Pseudomonas aeruginosa 215
Synthesis of some methylfurochromones as potential photochemotherapeutic agents. 215
8-AZAPSORALEN DERIVATIVES - ISOLATION AND CHARACTERIZATION OF THE FURAN-SIDE CYCLOADDUCTS WITH DNA 214
DNA damage induced by 4,6,8,9-tetramethyl-2H-furo[2,3-h]quinolin-2-one, a new furocoumarin analog: biological consequences 213
Exploring Epidermal Growth Factor Receptor (EGFR) Inhibitor Features: The Role of Fused Dioxygenated Rings on the Quinazoline Scaffold 208
Cell killing and DNA damage induced in cultured mammalian cells by some tetrahydrobenzopsoralenquinones 207
Coumarin as attractive casein kinase 2(CK2) inhibitor scaffold: an integrated approach to elucidate the putative binding motif and explain structure-activity relationship. 207
PHOTOBIOLOGICAL ACTIVITY OF CERTAIN NEW METHYLAZAPSORALENS 203
PYRROLOQUINOLINONE METHYLDERIVATIVES, FUROCOUMARIN ANALOGUES - SYNTHESIS AND BIOLOGICAL-ACTIVITY 202
Difurocoumarins, Psoralen Analogs: Synthesis and DNA Photobinding 201
Quinazoline-based kinase inhibitors: new synthetic approach and biological evaluation. 201
Discovery Of Biarylaminoquinazolines As Novel Tubulin Polymerization Inhibitors 200
Photophysical properties of halo-derivatives of angelicins 199
Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity 198
Pyrrolocoumarin derivatives: DNA-binding properties 198
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis 195
Methylpyranochromones and methylbenzodipyranones: new potential photoreagents towards DNA 192
On new aspects of biological activity of some psoralen derivatives 192
Methylfuroquinolinones: new furocoumarin isosters as potential photoreagents toward DNA. 192
Differential Effects of Angelicin Analogues on NF- κ B Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 190
Pyrroloquinolinone-based dual topoisomerase I/II inhibitor 188
13C-NMR Spectra and carbon-proton coupling constants of various annulated furocoumarins 187
Furochinazoline come potenziali bioisosteri di furocumarine: sintesi e proprieta’ fotobiologiche 187
Isostero angelicinico con duplice attività antiproliferativa, metodo per la sua preparazione e suoi impieghi in terapia 186
Photochemical and photobiological studies on furoquinazolines as new psoralen analogs 186
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 186
Development of a Novel Furocoumarin Derivative Inhibiting NF-kB Dependent Biological Functions: Design, Synthesis and Biological Effects 185
Activity of new benzo- and tetrahydrobenzopsoralen derivatives. 184
Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016) 182
Synthesis of novel psoralen derivatives as inhibitors of NF-kB dependent biological function 181
Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N’-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of Type III receptor tyrosine kinase subfamily 180
Sintesi di nuovi inibitori delle topoisomerasi. 179
Photobiological properties of 3-psoralenacetic acids 179
4-Anilinoquinazolines endowed with antiangiogenic activity 179
Microwave-promoted mono-N-alkylation of aromatic amines in water: a new efficient and green method for an old and problematic reaction 177
6-Arylpyrimidines as novel attractive scaffolds for ATP competitive KSP inhibition 177
Targeting tyrosine kinases: anti-proliferative and anti-angiogenic properties of 4-anilinoquinazolines 176
METHYLTRIAZOLOCOUMARINS - NEW FUROCOUMARIN ISOSTERS AS POTENTIAL PHOTOCHEMOTHERAPEUTIC AGENTS 176
Synthesis and evaluation of erlotinib analogues: exploiting ring closure 175
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: the critical role of the furan ring 174
Synthesis and antiproliferative activity of furocoumarin isosters. 173
Pyrrolocoumarin derivatives as potential photoreagents toward DNA. 171
Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010) 171
Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics 170
Synthesis and evaluation of tricyclic quinazoline derivatives as egfr inhibitors 170
Psoralen derivatives as NF-kB/DNA interaction inhibitors: structural insight into the binding mode 170
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 170
A novel approach to quinazolin-4(3H)-one via quinazoline oxidation: an improved synthesis of 4-anilinoquinazolines 169
Structure and reactivity of molecular ions of isomeric pyrroloquinolinones and benzoquinolizinones. 168
Discovery of novel wtRET and V804MRET inhibitors: from hit to lead 168
Photophysics and photodimerization of 6,5'-dimethylangelicin in different solvents 167
Biphenylaminoquinazolines as novel dual inhibitors of tyrosine kinases and tubulin polymerization: synthesis, SARs and anticancer properties 166
Photobiological properties of 3-psoralenacetic acids 164
Isomerization of 4-Aminobenzofurans to 4-Hydroxyindoles. 163
Biphenyl tricyclic quinazoline compounds 163
Furoquinazolines as furocoumarin analogs: can we improve solubility without impairing biological activity? 162
Synthesis of coumarin compounds as CK2 inhibitors. 160
REGIOSPECIFIC SYNTHESIS OF 1H,5H-BENZO[IJ]QUINOLIZIN-5-ONE AND 3H,5H-BENZO[IJ]QUINOLIZIN-5-ONE DERIVATIVES 159
Totale 20.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.405
article - articoli 59.515
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.648
selected - selezionate 0
volume - volumi 540
Totale 134.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.635 0 249 207 129 130 74 85 202 41 23 171 324
2022/20231.396 266 155 26 152 224 244 2 95 137 16 54 25
2023/2024798 43 120 110 56 52 117 33 57 26 28 92 64
2024/20252.890 5 128 163 158 484 62 119 149 276 97 495 754
2025/202612.146 503 956 1.541 1.856 1.287 533 1.474 1.096 1.173 798 578 351
2026/2027548 431 117 0 0 0 0 0 0 0 0 0 0
Totale 25.869